Jaguar Health Announces Employee Inducement Grants

Jaguar Health, Inc., a commercial-stage pharmaceutical company, has announced new employee inducement grants under Nasdaq Listing Rule 5635(c)(4). Effective October 7, 2024, the company granted 80,000 restricted stock units (RSUs) to New Employee 1 and 15,000 RSUs to each of four other new employees. These RSUs are intended as inducements for the acceptance of employment.

The RSUs for New Employee 1 will vest equally over three years, while those for the other four new employees will vest over one year. Vesting is contingent on their continued service with Jaguar Health. These inducement grants received approval from the Compensation Committee of Jaguar's Board.